Showing 741-750 of 4006 results for "".
ADCs Across the Spectrum of HER2 Expression in Metastatic Breast Cancer
https://reachmd.com/programs/cme/adcs-across-the-spectrum-of-her2-expression-in-metastatic-breast-cancer/32202/Dr. Reshma Mahtani presents patient case challenges highlighting the use of antibody-drug conjugates in HER2-expressing metastatic breast cancer.An Overview of Topical Therapies for Managing Pediatric AD
https://reachmd.com/topics/atopic-dermatitis/an-overview-of-topical-ththerapies-for-managing-pediatric-ad/54375/Moisturization is foundational in AD management; no specific formulation has demonstrated superiority, and excessive bathing may worsen disease via increased transepidermal water loss. Topical corticosteroids and calcineurin inhibitors remain first-line due to strong efficacy data, cost-effectiveneQuick Takes in ATTR-CM: Symptoms and Comorbidities
https://reachmd.com/programs/medical-industry-feature/attr-cm-symptoms-comorbidities/39766/Certain signs and symptoms can increase suspicion for transthyretin amyloid cardiomyopathy (ATTR-CM) even before clear cardiac involvement is present. Findings such as bilateral carpal tunnel syndrome, neuropathy, spinal stenosis, low blood pressure, and gastrointestinal symptoms, including weight lAdvancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
https://reachmd.com/programs/cme/advancing-bispecific-antibodies-upstream-in-the-treatment-paradigm-of-multiple-myeloma/49263/Review emerging evidence supporting earlier use of bispecific antibodies in multiple myeloma, with a focus on efficacy, safety, and optimizing patient outcomes.Challenge Case Report: New Onset Seizures
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/challenge-case-report-new-onset-seizures/31856/There have been significant advancements in the molecular characterization of brain tumors.Treatment Response Assessment Tools for Relapsing Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/treatment-response-assessment-tools-for-relapsing-multiple-sclerosis/33142/The authors explore available tools for assessing treatment response in relapsing multiple sclerosis and provide practical recommendations for their use in clinical practice.Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
https://reachmd.com/programs/cme/primary-care-for-the-brain-prevention-and-early-detection-of-cognitive-decline/39897/In this on-demand webcast, leading experts in brain health provide guidance for patient education, discussion, and management geared toward HCPs in primary care who are at the forefront of an aging population at risk of cognitive decline trying to plan for its future and for whom brain health is a tCoping After COVID: How Can We Help Long-Haulers?
https://reachmd.com/programs/covid-19-frontlines/coping-after-covid-how-can-we-help-long-haulers/12636/Shortness of breath, brain fog, and fatigue are some of the symptoms that just won’t seem to go away. Here’s what we know about COVID long-haulers.Regina Herzlinger on the Rise of Consumer-Driven Health Care
https://reachmd.com/programs/conversations-on-health-care/regina-herzlinger-on-the-rise-of-consumer-driven-health-care/6997/This week, Mark and Margaret speak with Regina Herzlinger, health industry expert and pioneer of the concept for consumer-driven health care. Ms. Herzlinger is the Nancy R. McPherson Professor of Business Administration Chair at the Harvard Business School. She was the first woman to be tenured andDr. Bennett Omalu on the Dangers of Concussions and CTE
https://reachmd.com/programs/clinicians-roundtable/dr-bennett-omalu-the-dangers-of-concussions-and-cte/9980/Dr. Bennett Omalu reflects on the aftermath of his original paper linking CTE to repeated brain trauma, and the dangers of high-contact sports.